SRS Capital Advisors Inc. Raises Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

SRS Capital Advisors Inc. lifted its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 308.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 408 shares of the company’s stock after purchasing an additional 308 shares during the period. SRS Capital Advisors Inc.’s holdings in U.S. Physical Therapy were worth $38,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of USPH. Quantbot Technologies LP bought a new stake in U.S. Physical Therapy during the 3rd quarter valued at $82,000. Benjamin Edwards Inc. lifted its stake in U.S. Physical Therapy by 17.4% in the fourth quarter. Benjamin Edwards Inc. now owns 1,692 shares of the company’s stock worth $158,000 after acquiring an additional 251 shares during the period. Park Avenue Securities LLC bought a new position in U.S. Physical Therapy during the 3rd quarter worth about $232,000. International Assets Investment Management LLC increased its position in U.S. Physical Therapy by 9,269.0% during the 4th quarter. International Assets Investment Management LLC now owns 2,717 shares of the company’s stock valued at $253,000 after purchasing an additional 2,688 shares during the period. Finally, HighTower Advisors LLC raised its holdings in shares of U.S. Physical Therapy by 47.2% in the 3rd quarter. HighTower Advisors LLC now owns 2,773 shares of the company’s stock valued at $257,000 after purchasing an additional 889 shares in the last quarter.

U.S. Physical Therapy Stock Up 1.5 %

Shares of U.S. Physical Therapy stock opened at $105.20 on Friday. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. The company has a market cap of $1.59 billion, a P/E ratio of 77.93, a PEG ratio of 4.99 and a beta of 1.39. The firm’s 50 day moving average price is $105.10 and its 200-day moving average price is $96.01. U.S. Physical Therapy, Inc. has a 52-week low of $78.08 and a 52-week high of $124.11.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.02. The business had revenue of $154.80 million for the quarter, compared to the consensus estimate of $150.24 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The business’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.58 earnings per share. On average, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.77 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.67%. The ex-dividend date of this dividend was Monday, March 11th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 130.37%.

Insider Transactions at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the transaction, the chief financial officer now directly owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 2,629 shares of U.S. Physical Therapy stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $104.39, for a total transaction of $274,441.31. Following the completion of the sale, the chief operating officer now owns 6,902 shares of the company’s stock, valued at approximately $720,499.78. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Carey P. Hendrickson sold 1,800 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the sale, the chief financial officer now owns 21,186 shares in the company, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,829 shares of company stock worth $1,141,535. Insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Barrington Research increased their price objective on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. Finally, JPMorgan Chase & Co. lifted their price target on U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a report on Wednesday, March 13th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $125.67.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.